Pharmacology, Toxicology and Pharmaceutical Science
Drug Utilization
100%
Adverse Outcome
55%
SARS Coronavirus
48%
Antibiotics
48%
Prescription Drug
35%
Proton Pump Inhibitor
34%
Paracetamol
34%
Cohort Study
30%
Chronic Obstructive Lung Disease
27%
Angiotensin Receptor Antagonist
27%
Non-Steroidal Anti-Inflammatory Drug
27%
Laxative
27%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
27%
Antithrombocytic Agent
27%
Multiple Chronic Conditions
22%
Combination Drug
20%
Isotopes of Potassium
20%
Analgesic Agent
20%
Dipeptidyl Carboxypeptidase Inhibitor
18%
Comorbidity
18%
Infection
18%
Bronchodilating Agent
17%
Case-Control Study
17%
Psoriasis
15%
Beta Adrenergic Receptor Blocking Agent
13%
Antihistaminic Agent
13%
Antidepressant
13%
Renin
13%
Angiotensin
13%
COVID-19 Vaccine
13%
Clinical Trial
13%
Pharmacotherapy
13%
Microscopic Colitis
13%
Omalizumab
13%
Upper Gastrointestinal Bleeding
13%
Chronic Urticaria
13%
Molnupiravir
13%
Budesonide
13%
Fragility Fracture
13%
Biological Product
13%
Psychotropic Agent
13%
Anticoagulant Agent
13%
Frailty
13%
Calcium Channel Blocker
12%
Amoxicillin
11%
Diseases
11%
Ustekinumab
11%
Side Effect
10%
Penicillin V
7%
Polypharmacy
6%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
55%
Adverse Outcome
55%
Cohort Analysis
43%
Nonsteroid Antiinflammatory Agent
27%
Angiotensin Receptor Antagonist
27%
COVID-19
23%
Intensive Care Unit
22%
Attributable Risk
21%
Comorbidity
20%
Odds Ratio
19%
ACE Inhibitor
18%
Infection
18%
Drug Use
15%
Nursing Home
13%
Reverse Transcription Polymerase Chain Reaction
13%
Bronchodilating Agent
13%
Budesonide
13%
Fragility Fracture
13%
Renin Angiotensin Aldosterone System
13%
Proton-Pump Inhibitor
13%
Cohort Effect
13%
Microscopic Colitis
13%
COVID-19 Vaccine
13%
Calcium Channel Blocking Agent
12%
Health Care
7%
Artificial Respiration
6%
Spine Fracture
5%
Nursing and Health Professions
Adverse Outcome
41%
Cohort Analysis
29%
Severe Acute Respiratory Syndrome
27%
Angiotensin Receptor Antagonist
27%
Dipeptidyl Carboxypeptidase Inhibitor
18%
Intensive Care Unit
18%
Health Care
18%
Infection
16%
Attributable Risk
14%
Nonsteroid Antiinflammatory Agent
13%
Angiotensin
13%
Renin
13%
Drug Use
13%
Nursing Home
13%
Automutilation
13%
Hospital Discharge
13%
Comorbidity
12%
Propensity Score
6%
